SERPINE2 and Patent ductus arteriosus: SERPINE2 boosts the in vivo invasiveness of its highly metastatic cancer cells via LRP1-mediated induction of MMP9 (35), and SERPINE2 indirectly enhances the invasive potential of cancer cells in PDA by activating surrounding stromal cells (36).